A model of Down’s syndrome, itself a “model” of Alzheimer’s disease, has virtually no retrograde transport of NGF to the ChBF cell bodies, and it is possible that likewise there is a defect in retrograde transport of NGF in Alzheimer’s disease. The gene discussed is NGF; the disease is Down syndrome.